ONO PHARMACEUTICAL CO
Clinical Trials
168
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (98 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 144
- Registration Number
- NCT06948448
ONO-4538 Study in Patients With Richter's Transformation
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT06936943
- Locations
- 🇯🇵
National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
🇯🇵Hokkaido University Hospital, Sapporo, Hokkaido, Japan
🇯🇵Kyusyu University Hospital, Fukuoka, Japan
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 240
- Registration Number
- NCT06881836
- Locations
- 🇺🇸
Profound Research LLC at The Neurology Center of Southern California, Carlsbad, California, United States
🇺🇸Ark Clinical Research, Fountain Valley, California, United States
🇺🇸Sunwise Clinical Research, Walnut Creek, California, United States
A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT06816108
- Locations
- 🇯🇵
National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
🇯🇵Osaka International Cancer Institute, Osaka-shi, Osaka, Japan
🇯🇵The Cancer Institute Hospital Of JFCR, Koto-Ku, Tokyo, Japan
A Study of ONO-1110 in Patients With Social Anxiety Disorder
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06805565
- Locations
- 🇯🇵
Kokura Mental Clinic, Fukuoka, Japan
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next